Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Commissioner Confirmation Clears The Way For Personnel Changes

This article was originally published in The Tan Sheet

Executive Summary

The confirmation of FDA Commissioner Lester Crawford will allow for a reorganization of upper level management at the agency

You may also be interested in...

Crawford Confirmation Expected To Move Issues Off The Back Burner

The confirmation of Lester Crawford as FDA Commissioner gives him three and a half years to cement his leadership, which has been under fire during his service as acting commissioner

FDA’s Sachdev resigns

Deputy Commissioner for Policy Amit Sachdev formally resigns from the agency, Acting Commissioner Lester Crawford announces in an internal memorandum. Crawford cited Sachdev's work with Congress on FDA oversight, his contributions to expanding the agency's access to more resources for its various centers and leadership in speeding up review of medicines to treat HIV/AIDS under the White House's global AIDS initiative. Sachdev, whose last day was March 25, has not disclosed his future plans...

McClellan Leaves For CMS As Crawford Heads Reorganized FDA

FDA Commissioner Mark McClellan, MD/PhD, is leaving FDA before the agency makes a decision on whether Barr Labs' Plan B (levenorgestrel .75 mg) is approvable for over-the-counter use

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts